Brickell Biotech Inc expected to post a loss of 12 cents a share - Earnings Preview

Fresh Tracks Therapeutics

10/08/2021 12:55

* Brickell Biotech Inc  BBI.OQ   BBI.O  is expected to report
results on August 12.
* The Boulder, Colorado-based company is expected to report
revenue of $50 thousand, according to the mean estimate from 2
analysts, based on Refinitiv data.  
​* Refinitiv's mean analyst estimate for Brickell Biotech Inc is
for a loss of 12 cents per share. 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Brickell
Biotech Inc is $5.5​, about 87.9% above​ its last closing price
of $0.67. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.11       -0.11      -0.15     Missed  -30.4
 Dec. 31 2020  -0.09       -0.09      -0.15     Missed  -66.7
 Sep. 30 2020  -0.19       -0.18      -0.15     Beat    18.9​
 ​​            ​                                        ​
                                                        ​
 Jun. 30 2019  -0.98       -0.77      -0.77     Met     0
 This summary was machine generated August 10 at 11:55 GMT.  All
figures in US dollars unless otherwise stated